A nut allergy IgE panel measures antibodies to peanut and selected tree nuts, such as cashew, pistachio, walnut, pecan, hazelnut, almond, Brazil nut, and macadamia. The panel can help investigate immediate reactions, but it often creates misleading positives when ordered as a broad screen. Peanut is a legume, not a tree nut, and each tree nut is a separate food. A positive result therefore shows sensitization to that individual extract; it does not prove allergy to every nut or predict the severity of a future reaction. Component testing can improve specificity for certain foods by identifying IgE to proteins associated with genuine systemic allergy, such as Ara h 2 in peanut, Ana o 3 in cashew, Cor a 14 in hazelnut, and Jug r 1 in walnut. Even component results require a matching history. Oral food challenges remain the reference standard when diagnosis is uncertain, and selective challenges may prevent unnecessary lifelong avoidance of nuts that are actually tolerated.
- A positive nut-panel result means sensitization, not confirmed clinical allergy, especially when the food has never caused symptoms.
- Peanut and tree nuts must be interpreted separately; allergy to one does not automatically mean allergy to all.
- Storage-protein components such as Ara h 2, Ana o 3, Cor a 14, and Jug r 1 can strengthen evidence of true systemic allergy.
- Pollen-related components may explain mouth itching and low-level positives, particularly with hazelnut or peanut.
- No IgE value predicts the exact severity of the next reaction, and challenge decisions use age, history, skin testing, asthma, and local cutoffs.
- Breathing difficulty, throat swelling, faintness, or rapidly progressing symptoms after a nut exposure require epinephrine when prescribed and emergency care.
Table of Contents
- What a Nut Allergy Panel Tests
- Whole-Extract and Component Testing
- Cross-Reactivity Between Nuts
- Interpreting Positive and Negative Results
- Oral Food Challenges and Selective Introduction
- Testing Mistakes That Lead to Overdiagnosis
- Living Safely With Confirmed Nut Allergy
- Planning Follow-Up
What a Nut Allergy Panel Tests
A laboratory “nut panel” is usually a menu of separate specific IgE assays reported together. It may include peanut plus several tree nuts, but the exact foods vary by laboratory. The report should be read line by line rather than treated as one combined positive or negative result.
Peanut belongs to the legume family, alongside soy, peas, lentils, and beans. Tree nuts come from different botanical families. Common panel items include:
- almond;
- Brazil nut;
- cashew;
- hazelnut;
- macadamia;
- pecan;
- pistachio;
- walnut;
- sometimes pine nut or chestnut;
- peanut, although it is not botanically a nut.
Each assay measures IgE binding to an extract made from that food. Results are generally expressed in kUA/L and may be assigned a class from 0 to 6. The class is only a concentration band. It is not a severity grade and does not mean class 4 is four times more dangerous than class 1.
Coconut, nutmeg, water chestnut, and shea are often confused with tree nuts in everyday language. Coconut is botanically a fruit, nutmeg is a seed used as a spice, and water chestnut is an aquatic vegetable. Their allergy patterns do not follow automatically from a peanut or tree nut panel. Sesame and other seeds are also separate allergens, even though they may share storage-protein families and appear in the same foods. The laboratory requisition should name the exact food rather than relying on a broad word such as “nuts.”
Panel composition also matters when comparing old and new reports. One laboratory may include eight foods, another five, and a third may add sesame or coconut. A “panel positive” statement without the individual analytes is clinically incomplete. Obtain the original report, including values, units, detection limits, and component names. This prevents a patient from being labeled allergic to a food that was never tested and avoids confusing a whole-extract result with a molecular component. Exact documentation also makes later trend comparisons safer and more meaningful.
The panel should be targeted to the clinical history. If a person developed hives and wheezing within minutes of cashew ingestion, testing cashew and closely related pistachio is logical. Testing ten nuts that the person eats without symptoms is less helpful and may create false labels.
A specific IgE blood test detects sensitization. Clinical allergy requires reproducible symptoms after exposure or confirmation by an oral food challenge. People with eczema, pollen allergy, or high total IgE often have low-level positive results to foods they tolerate.
A negative result lowers the likelihood of IgE-mediated allergy but does not erase a highly convincing immediate reaction. Extract composition, assay sensitivity, timing, and the specific protein involved can affect detection. A specialist may add skin-prick testing, component testing, or a supervised challenge.
Whole-Extract and Component Testing
Whole-extract testing asks whether IgE binds any protein in the food extract. Component-resolved testing asks which individual protein is recognized. The protein family often provides more clinical information than the total extract value.
Peanut components
Peanut components include storage proteins, profilin, and proteins related to birch pollen. Ara h 2 is a 2S albumin storage protein and is one of the most useful markers of genuine peanut allergy. Ara h 1, Ara h 3, and Ara h 6 are also storage proteins linked with systemic reactions. Ara h 8 resembles the birch pollen allergen Bet v 1 and often appears in people with pollen-food syndrome, where symptoms may be limited to mouth or throat itching after raw peanut exposure. Ara h 9 is a lipid transfer protein that can be important in Mediterranean and other populations.
A dedicated peanut component IgE test can reduce uncertainty when whole-peanut IgE is positive but the history is unclear. Ara h 2 has better diagnostic specificity than whole-peanut extract in many populations, yet it still does not provide a universal yes-or-no cutoff.
Cashew and pistachio
Ana o 3, a cashew 2S albumin, is strongly associated with genuine cashew allergy and can improve diagnostic accuracy. Cashew and pistachio are closely related botanically, so clinical cross-reactivity is common. A person allergic to cashew may need evaluation for pistachio even without prior ingestion, but the relationship does not automatically prove both allergies.
Hazelnut
Hazelnut testing is especially vulnerable to birch-pollen cross-reactivity. Cor a 1 is a Bet v 1–related protein and often corresponds to pollen-food syndrome with oral symptoms. Cor a 9 and Cor a 14 are storage proteins more strongly linked with primary hazelnut allergy and systemic reactions. Cor a 8, a lipid transfer protein, can be important in some regions.
Walnut and pecan
Jug r 1 is a walnut 2S albumin associated with primary walnut allergy. Walnut and pecan are closely related, and co-allergy is common. Component availability and evidence differ by laboratory and population.
Other nuts
Components exist for Brazil nut, almond, and other foods, but their clinical validation is less uniform. A positive component should be interpreted according to the exact protein, assay, geographic region, and patient age.
| Food | Component | Typical interpretation |
|---|---|---|
| Peanut | Ara h 2 or Ara h 6 | Storage-protein sensitization; stronger association with genuine systemic allergy |
| Peanut | Ara h 8 | Often birch-related pollen-food syndrome |
| Cashew | Ana o 3 | Improves evidence for primary cashew allergy |
| Hazelnut | Cor a 9 or Cor a 14 | Storage-protein sensitization; higher concern for systemic allergy |
| Hazelnut | Cor a 1 | Often birch-pollen cross-reactivity and oral symptoms |
| Walnut | Jug r 1 | Supports primary walnut allergy |
Cross-Reactivity Between Nuts
Cross-reactivity occurs when IgE recognizes similar proteins in different foods. It can produce a positive test to a food never eaten, but a laboratory cross-reaction does not always cause symptoms.
The strongest clinically relevant pairs are:
- cashew and pistachio;
- walnut and pecan.
These pairs share related storage proteins, so allergists often evaluate them together. Even then, one member can be tolerated. A supervised challenge may clarify the second food when the history and tests support it.
Hazelnut, almond, and some other nuts can cross-react with pollens through profilins or Bet v 1–like proteins. This often causes pollen-food syndrome: itching, tingling, or mild swelling in the mouth after raw foods. Heating may reduce symptoms for some Bet v 1–related foods, but roasting does not reliably make all nuts safe because heat-stable storage proteins remain.
Peanut can cross-react in laboratory testing with other legumes, but most peanut-allergic people tolerate beans, peas, lentils, and soy. Avoiding the entire legume family without symptoms is usually unnecessary.
Co-allergy and cross-sensitization are different. Co-allergy means two foods both cause reactions. Cross-sensitization means IgE recognizes both in a test. A person may test positive to five nuts but react to only one or two.
Manufacturing cross-contact creates a separate issue. A person may tolerate almond itself but avoid a mixed-nut product because it contains or is contaminated with cashew. This is not immunologic cross-reactivity; it is exposure to a different allergen.
The decision to avoid all nuts is individualized. Broad avoidance may simplify labeling and reduce cross-contact risk, particularly in young children, but it also removes nutritious tolerated foods and can increase anxiety. Current management increasingly favors identifying tolerated nuts when this can be done safely and practically.
Continued ingestion of tolerated nuts may help preserve them as normal foods, although evidence does not support unsupervised introduction when testing or history raises concern. The plan should specify exact species, forms, brands, and cross-contact precautions.
Interpreting Positive and Negative Results
A result gains meaning from pretest probability—the likelihood of allergy before testing. Immediate hives, vomiting, wheeze, or faintness after eating a specific nut creates a high pretest probability. A low positive in someone who regularly eats that nut without symptoms has little clinical importance.
Low positive extract IgE may reflect early sensitization, pollen cross-reactivity, high total IgE, or clinically irrelevant binding. It should not automatically lead to avoidance.
High extract IgE with a matching reaction strongly supports allergy, but it still cannot predict the exact severity or threshold dose. Challenge may be unnecessary when the diagnosis is already clear and the risk outweighs the benefit.
Storage-protein component positivity generally increases concern for a genuine systemic allergy. The stronger evidence for Ara h 2, Ana o 3, Cor a 14, and related proteins helps reduce unnecessary challenges, but cutoffs differ by age, assay, and population.
Pollen-related component positivity may shift the diagnosis toward pollen-food syndrome, especially when symptoms are confined to the mouth and occur during pollen season. Systemic reactions remain possible, so component type does not replace clinical judgment.
Negative extract and component tests make IgE-mediated allergy less likely. A supervised challenge may be appropriate if the food has been avoided only because of another nut allergy. After a convincing severe reaction, negative results may lead to repeat testing, skin testing, or careful specialist review rather than immediate home introduction.
Values should be followed on the same platform when possible. Falling IgE can support reassessment, but a percentage decline is not proof of tolerance. Rising values can reflect biological variation or changing eczema and do not necessarily mean reaction severity has increased.
No laboratory class predicts anaphylaxis. Severe reactions can occur at low values, and high values can coexist with a history of only mild symptoms. Asthma control, amount eaten, exercise, infection, alcohol, NSAIDs, and delay in epinephrine influence clinical severity.
A high total IgE level can reduce the specificity of multiple low food-specific results. Some specialists consider specific-to-total IgE relationships in selected cases, but ratios are not universal diagnostic rules.
Oral Food Challenges and Selective Introduction
An oral food challenge is the reference standard when history and testing do not provide a clear answer. It involves measured doses given under medical observation with staff and medicines ready to treat a reaction.
Challenges are especially useful when:
- a nut has been avoided only because another nut caused a reaction;
- extract IgE is low or declining;
- component testing suggests pollen cross-reactivity rather than storage-protein allergy;
- a patient has never eaten the nut and wants to broaden the diet;
- the original reaction was vague or occurred many years ago;
- the result would meaningfully improve nutrition, convenience, or quality of life.
A challenge may be postponed when recent anaphylaxis, uncontrolled asthma, strongly positive storage proteins, very high pretest probability, acute illness, pregnancy, or inability to stop interfering medicines increases risk. The decision is individualized; no single cutoff applies everywhere.
The challenge food must be the correct species. “Mixed nuts” cannot identify which nut caused symptoms. Doses are increased at intervals until a full serving or stopping criterion is reached. Observation continues after the final dose.
Passing a challenge means that the tested amount and form were tolerated that day. The allergist usually recommends regular ingestion to keep the food in the diet. The plan should state how often, how much, and what products are acceptable. Families need guidance on cross-contact with the confirmed allergen.
Home introduction is different from a clinical challenge. It may be appropriate only when the allergist judges the risk very low and provides exact instructions. A positive storage-protein result, prior systemic reaction, or uncontrolled asthma generally argues against improvising at home.
Selective challenges can transform a broad “all nuts” label into a precise list. This may allow safe use of almond, hazelnut, or another tolerated nut while maintaining strict avoidance of cashew or walnut. Precision improves nutrition and reduces the number of accidental exposures caused by confusing restrictions.
Testing Mistakes That Lead to Overdiagnosis
The most common mistake is ordering a large panel before asking what happened. The more foods tested, the more likely at least one result will be positive by chance or cross-reactivity.
Other frequent errors include:
- testing nuts that are eaten regularly without symptoms;
- treating every value above 0.35 kUA/L as allergy;
- assuming peanut allergy proves tree nut allergy;
- assuming one tree nut result applies to all tree nuts;
- ignoring birch pollen or other aeroallergen sensitization;
- using old reaction history without reassessing whether allergy has resolved;
- comparing classes across different laboratories;
- interpreting a component name without knowing its protein family;
- using IgG food panels, hair analysis, electrodermal testing, or other unvalidated methods;
- introducing a nut at home solely because a number is “low.”
A broad positive panel can lead to years of avoidance, school restrictions, anxiety, higher food costs, and nutritional loss. It may also obscure the genuinely dangerous nut by treating every item as equivalent.
Underdiagnosis has its own risks. Dismissing immediate symptoms because a whole-extract test is negative may miss an underrepresented component. A strong history deserves specialist evaluation.
Testing should be repeated only when the answer could change management. Annual panels without a challenge plan can create numerical monitoring with no clinical benefit. A useful follow-up asks: if this level falls, will we offer a challenge; if it rises, will anything change?
Living Safely With Confirmed Nut Allergy
Confirmed allergy requires species-specific avoidance and an emergency plan. Ingredient labels should be read every time because recipes and manufacturing sites change. Laws differ in how peanut and individual tree nuts must be declared, and precautionary phrases such as “may contain” do not quantify risk.
High-risk settings include bakeries, ice cream shops, dessert counters, chocolate production, Asian and Middle Eastern restaurants, vegan foods using cashew cream, pesto, mixed-nut products, and shared scoops or grinders. Nut oils vary: highly refined oils may contain little protein, while cold-pressed or unrefined oils can retain allergen. Product decisions belong in the individual allergy plan.
The person should carry epinephrine auto-injectors when prescribed. Epinephrine is first-line for breathing problems, throat symptoms, faintness, repetitive vomiting with other symptoms, or rapidly progressing reactions. Antihistamines may relieve isolated itching or hives but do not prevent airway obstruction or shock.
Asthma should be well controlled. Poorly controlled asthma can complicate food reactions and make respiratory symptoms harder to interpret. Schools, childcare, workplaces, and travel companions need a written action plan and training.
Tolerated nuts should be handled deliberately. Store them separately, choose products with acceptable cross-contact labeling, and avoid mixed containers. A person allergic to cashew but tolerant of almond may still react to almond from a bulk bin contaminated with cashew.
Immunotherapy and biologic treatment are evolving. Peanut oral immunotherapy and other approaches can raise the amount tolerated during accidental exposure but do not cure allergy or permit unrestricted eating. Omalizumab may reduce reaction risk to accidental exposures in eligible patients with multiple food allergies. Treatment selection requires specialist discussion of goals, adverse effects, burden, and ongoing avoidance.
Planning Follow-Up
Follow-up should focus on unanswered questions rather than repeating the same broad panel. Bring a list of nuts that are definitely tolerated, definitely reacted to, never eaten, or avoided only because of another allergy.
Ask the allergist:
- Which panel results match real reactions?
- Which positives may be caused by pollen cross-reactivity?
- Would Ara h 2, Ana o 3, Cor a 14, Jug r 1, or another component change the plan?
- Which closely related nut pair needs evaluation?
- Are any avoided nuts suitable for a supervised challenge?
- How should tolerated nuts be kept in the diet?
- What cross-contact situations require avoidance?
- When should IgE or skin testing be repeated?
- Is asthma controlled enough for a challenge?
- Does the emergency plan specify when to use epinephrine?
Children may outgrow some tree nut allergies, although persistence is common. Adults can also have changing sensitization patterns. Reassessment is reasonable when values decline, the original diagnosis was uncertain, or dietary expansion would provide a meaningful benefit.
The final diagnosis should be a clear list, not the phrase “nut allergy” alone. It should name confirmed allergens, tolerated nuts, untested nuts, challenge plans, and emergency treatment. That precision is the main clinical value of moving from a broad panel toward component testing and selective food challenges.
References
- EAACI guidelines on the diagnosis of IgE-mediated food allergy 2023 (Guideline)
- Tree Nut Allergy in Children—What Do We Know? —A Review 2024 (Review)
- Oral Food Challenge in Children with Tree Nut and Peanut Allergy: The Predictive Value of Diagnostic Tests 2024 (Review)
- A diagnostic approach to IgE-mediated food allergy: A practical algorithm 2024 (Review)
- Canadian Society of Allergy and Clinical Immunology position statement: panel testing for food allergies 2024 (Position Statement)
- Update on Tree Nut and Seed Allergies: Prevalence, Clinical Characteristics, Diagnosis, and Management 2025 (Review)
Disclaimer
This article provides general information and cannot diagnose a peanut or tree nut allergy. Do not stop eating a tolerated nut, introduce an avoided nut, or perform a food challenge based only on panel results; use an allergist’s individualized plan. Severe symptoms require epinephrine when prescribed and emergency care.
